Study: Elinzanetant cuts vasomotor symptoms in women with breast cancer on endocrine therapy

Published Date: 04 Jun 2025

For women with moderate-to-severe vasomotor symptoms associated with endocrine therapy for hormone receptor (HR)-positive breast cancer, elinzanetant, a neurokinin-targeted therapy, reduces the frequency of vasomotor symptoms, ...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Teenagers Frequently Use Delta-8 THC; New Drug-Coated Balloon Treats Blocked Stents.

2.

Immunotherapy after surgery is good for patients with advanced cancer

3.

AI-based liquid biopsy shows promise for detecting brain cancer

4.

Oncologist Sued for Double-Billing; Pharmacy Deserts; 'She Loved Scotch and Pizza'

5.

New BCMA-Directed Therapies Show Promise in Multiple Myeloma


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot